| DAA699 |
Triglyceride levels increase |
— |
plasma |
Human |
|
| DAA900 |
Urine concentrating capacity decreases |
— |
renal tubule |
Human |
|
| DAA966 |
Vaccination antibody response is impaired |
— |
immune system |
Human |
|
| DAA1061 |
Variability in clearance of hepatically metabolized drugs |
— |
liver |
Human |
|
| DAA2043 |
Variations in body weight |
— |
whole body |
Human |
|
| DAA2044 |
Variations in fat mass |
— |
adipose tissue |
Human |
|
| DAA896 |
Vasodilation induced by acetylcholine or sodium reduced |
— |
renal vasculature |
Human |
|
| DAA794 |
Ventilatory rate at maximum exertion decreases |
— |
lung |
Human |
|
| DAA788 |
Viscoelastic modulus of brain tissue decreases |
— |
brain |
Human |
|
| DAA2583 |
Vision loss |
— |
visual apparatus |
Human |
|
| DAA936 |
Volume of hematopoietic bone marrow decreases |
— |
bone marrow |
Human |
|
| DAA948 |
Volume of perivascular space around thymus increases |
— |
thymus |
Human |
|
| DAA703 |
Wall increases in thickness |
— |
left ventricle |
Human |
|
| DAA846 |
Weakening of intestinal wall |
— |
large intestine |
Human |
|
| DAA826 |
Weaker digestive tract muscle contractions |
— |
alimentary system, smooth muscle |
Human |
|
| DAA730 |
White matter volume decreases |
— |
white matter |
Human |
|
| DAA884 |
Widespread degeneration of glomerular blood vessels |
— |
renal vasculature |
Human |
|
| DAA1003 |
Wrinkles |
— |
skin |
Human |
|
| DAA1960 |
Adipocyte formation increases |
— |
bone marrow |
Mouse |
|
| DAA1934 |
Body weight declines |
— |
whole body |
Mouse |
|
| DAA1974 |
Bone loss |
— |
bone |
Mouse |
|
| DAA2037 |
Decrease in mitochondrial content and oxidative metabolism in cells |
— |
brain |
Mouse |
|
| DAA1950 |
D-glucose absorption decreased |
— |
endocrine system |
Mouse |
|
| DAA988 |
Function declines |
— |
dendritic cell |
Mouse |
|
| DAA1941 |
Gait width increases |
— |
nervous system |
Mouse |
|